113 related articles for article (PubMed ID: 37523668)
1. Molecular dissection of anti-colon cancer activity of NARI-29: special focus on H
Np S; Rajdev B; Jain S; Gangasani JK; Vaidya JR; Naidu V
Free Radic Res; 2023 Apr; 57(4):308-324. PubMed ID: 37523668
[TBL] [Abstract][Full Text] [Related]
2. Pivotal role of AKR1B1 in pathogenesis of colitis associated colorectal carcinogenesis.
Syamprasad NP; Rajdev B; Jain S; Panda SR; Puppala ER; Chaudhari P; Vaidya JR; Kumar GJ; Naidu VGM
Int Immunopharmacol; 2023 Jun; 119():110145. PubMed ID: 37044030
[TBL] [Abstract][Full Text] [Related]
3. AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis.
Syamprasad NP; Jain S; Rajdev B; Panda SR; Gangasani JK; Challa VS; Vaidya JR; Kundu GC; Naidu VGM
Chem Biol Interact; 2023 Aug; 381():110566. PubMed ID: 37257577
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase inhibition enhances TRAIL-induced human colon cancer cell apoptosis through AKT/FOXO3a-dependent upregulation of death receptors.
Shoeb M; Ramana KV; Srivastava SK
Free Radic Biol Med; 2013 Oct; 63():280-90. PubMed ID: 23732517
[TBL] [Abstract][Full Text] [Related]
5. Gedunin, A Neem Limonoid in Combination with Epalrestat Inhibits Cancer Hallmarks by Attenuating Aldose Reductase-Driven Oncogenic Signaling in SCC131 Oral Cancer Cells.
Tanagala KKK; Baba AB; Kowshik J; Reddy GB; Nagini S
Anticancer Agents Med Chem; 2018; 18(14):2042-2052. PubMed ID: 30062975
[TBL] [Abstract][Full Text] [Related]
6. OSMI-1 Enhances TRAIL-Induced Apoptosis through ER Stress and NF-κB Signaling in Colon Cancer Cells.
Lee SJ; Lee DE; Choi SY; Kwon OS
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681736
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin.
Jani TS; DeVecchio J; Mazumdar T; Agyeman A; Houghton JA
J Biol Chem; 2010 Jun; 285(25):19162-72. PubMed ID: 20424169
[TBL] [Abstract][Full Text] [Related]
8. 2-Tellurium-bridged β-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression.
Lin T; Ding Z; Li N; Xu J; Luo G; Liu J; Shen J
Carcinogenesis; 2011 Feb; 32(2):154-67. PubMed ID: 21081474
[TBL] [Abstract][Full Text] [Related]
9. (4-Oxo-2-thioxothiazolidin-3-yl)acetic acids as potent and selective aldose reductase inhibitors.
Kucerova-Chlupacova M; Halakova D; Majekova M; Treml J; Stefek M; Soltesova Prnova M
Chem Biol Interact; 2020 Dec; 332():109286. PubMed ID: 33038328
[TBL] [Abstract][Full Text] [Related]
10. ROS and CHOP are critical for dibenzylideneacetone to sensitize tumor cells to TRAIL through induction of death receptors and downregulation of cell survival proteins.
Prasad S; Yadav VR; Ravindran J; Aggarwal BB
Cancer Res; 2011 Jan; 71(2):538-49. PubMed ID: 21127198
[TBL] [Abstract][Full Text] [Related]
11. Icariin sensitizes human colon cancer cells to TRAIL‑induced apoptosis via ERK‑mediated upregulation of death receptors.
Kim B; Seo JH; Lee KY; Park B
Int J Oncol; 2020 Mar; 56(3):821-834. PubMed ID: 32124960
[TBL] [Abstract][Full Text] [Related]
12. BAY61-3606 potentiates the anti-tumor effects of TRAIL against colon cancer through up-regulating DR4 and down-regulating NF-κB.
Du J; Wang Y; Chen D; Ji G; Ma Q; Liao S; Zheng Y; Zhang J; Hou Y
Cancer Lett; 2016 Dec; 383(2):145-153. PubMed ID: 27721019
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.
Izeradjene K; Douglas L; Tillman DM; Delaney AB; Houghton JA
Cancer Res; 2005 Aug; 65(16):7436-45. PubMed ID: 16103097
[TBL] [Abstract][Full Text] [Related]
14. Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis.
Szliszka E; Zydowicz G; Janoszka B; Dobosz C; Kowalczyk-Ziomek G; Krol W
Int J Oncol; 2011 Apr; 38(4):941-53. PubMed ID: 21286663
[TBL] [Abstract][Full Text] [Related]
15. A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.
Dai Y; Liu M; Tang W; Li Y; Lian J; Lawrence TS; Xu L
BMC Cancer; 2009 Nov; 9():392. PubMed ID: 19895686
[TBL] [Abstract][Full Text] [Related]
16. Anti-neuroinflammatory efficacy of the aldose reductase inhibitor FMHM via phospholipase C/protein kinase C-dependent NF-κB and MAPK pathways.
Zeng KW; Li J; Dong X; Wang YH; Ma ZZ; Jiang Y; Jin HW; Tu PF
Toxicol Appl Pharmacol; 2013 Nov; 273(1):159-71. PubMed ID: 24021941
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation.
Chen JJ; Chou CW; Chang YF; Chen CC
J Immunol; 2008 Jun; 180(12):8030-9. PubMed ID: 18523266
[TBL] [Abstract][Full Text] [Related]
18. miR-128 Targets the SIRT1/ROS/DR5 Pathway to Sensitize Colorectal Cancer to TRAIL-Induced Apoptosis.
Lian B; Yang D; Liu Y; Shi G; Li J; Yan X; Jin K; Liu X; Zhao J; Shang W; Zhang R
Cell Physiol Biochem; 2018; 49(6):2151-2162. PubMed ID: 30257253
[TBL] [Abstract][Full Text] [Related]
19. The AKR1B1 inhibitor epalrestat suppresses the progression of cervical cancer.
Ji J; Xu MX; Qian TY; Zhu SZ; Jiang F; Liu ZX; Xu WS; Zhou J; Xiao MB
Mol Biol Rep; 2020 Aug; 47(8):6091-6103. PubMed ID: 32761301
[TBL] [Abstract][Full Text] [Related]
20. Ilimaquinone induces death receptor expression and sensitizes human colon cancer cells to TRAIL-induced apoptosis through activation of ROS-ERK/p38 MAPK-CHOP signaling pathways.
Do MT; Na M; Kim HG; Khanal T; Choi JH; Jin SW; Oh SH; Hwang IH; Chung YC; Kim HS; Jeong TC; Jeong HG
Food Chem Toxicol; 2014 Sep; 71():51-9. PubMed ID: 24930757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]